Roberts Eiry
Officer at NBIX
- Sold, on record
- $21.2M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Feb 14, 2025
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NBIXNEUROCRINE BIOSCIENCES INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice NBIXNoticeJan 31, 2025 2025
Filed to sell 1,457 shares ($223k)
Roberts Eiry, Officer
10b5-1 plan0.2x usual sizeFiling
- 2 Form 4 sale NBIXRoutineJan 31, 2025 same day
Sold 1,457 shares at $152.80 ($223k)
Roberts Eiry, Chief Medical Officer
10b5-1 planSold 4.3% of holdings ($5.2M position)32,373 shares left0.2x usual sizeFollows a Form 144Filing
- 3 Form 144 notice NBIXNoticeFeb 10, 2025 +10 days
Filed to sell 980 shares ($120k)
Roberts Eiry, Officer
10b5-1 plan0.2x usual sizeFiling
- 4 Form 4 sale NBIXRoutineFeb 10, 2025 same day
Sold 980 shares at $118.22 ($116k)
Roberts Eiry, Chief Medical Officer
10b5-1 planSold 2.9% of holdings ($4M position)33,253 shares left0.2x usual sizeFollows a Form 144Filing
- 5 Form 144 notice NBIXNoticeFeb 13, 2025 +3 days
Filed to sell 1,114 shares ($131k)
Roberts Eiry, Officer
10b5-1 plan0.3x usual sizeFiling
- 6 Form 144 notice NBIXNoticeFeb 13, 2025 same day
Filed to sell 604 shares ($71k)
Roberts Eiry, Officer
10b5-1 plan0.2x usual sizeFiling
- 7 Form 4 sale NBIXRoutineFeb 14, 2025 +1 day
Sold 2,218 shares at $116.44 ($258k)
Roberts Eiry, Chief Medical Officer
10b5-1 planSold 5.9% of holdings ($4.4M position)35,640 shares left0.7x usual sizeFollows a Form 144Filing
- 8 Form 144 notice NBIXNoticeFeb 14, 2025 same day
Filed to sell 500 shares ($58k)
Roberts Eiry, Officer
No 10b5-1 plan0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (37)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Feb 14, 2025 | NBIX | Officer | Form 144 notice | 500 | $58k | Notice | SEC | |
| Feb 14, 2025 | Feb 14, 2025 | NBIX | Chief Medical Officer | Form 4 sale | 2,218 | $258k | 5.9% | Routine | SEC |
| Feb 13, 2025 | Feb 13, 2025 | NBIX | Officer | Form 144 notice | 604 | $71k | Notice | SEC | |
| Feb 13, 2025 | Feb 13, 2025 | NBIX | Officer | Form 144 notice | 1,114 | $131k | Notice | SEC | |
| Feb 10, 2025 | Feb 12, 2025 | NBIX | Chief Medical Officer | Form 4 sale | 980 | $116k | 2.9% | Routine | SEC |
| Feb 10, 2025 | Feb 10, 2025 | NBIX | Officer | Form 144 notice | 980 | $120k | Notice | SEC | |
| Jan 31, 2025 | Feb 4, 2025 | NBIX | Chief Medical Officer | Form 4 sale | 1,457 | $223k | 4.3% | Routine | SEC |
| Jan 31, 2025 | Jan 31, 2025 | NBIX | Officer | Form 144 notice | 1,457 | $223k | Notice | SEC | |
| Feb 13, 2024 | Feb 15, 2024 | NBIX | Chief Medical Officer | Form 4 sale | 1,114 | $148k | 4.5% | Routine | SEC |
| Feb 13, 2024 | Feb 13, 2024 | NBIX | Officer | Form 144 notice | 1,114 | $145k | Notice | SEC | |
| Feb 8, 2024 | Feb 8, 2024 | NBIX | Chief Medical Officer | Form 4 sale | 2,101 | $291k | 8.5% | Routine | SEC |
| Feb 6, 2024 | Feb 6, 2024 | NBIX | Officer | Form 144 notice | 2,101 | $298k | Notice | SEC | |
| Jan 31, 2024 | Feb 2, 2024 | NBIX | Chief Medical Officer | Form 4 sale | 1,457 | $205k | 6.5% | Routine | SEC |
| Jan 31, 2024 | Jan 31, 2024 | NBIX | Officer | Form 144 notice | 1,457 | $207k | Notice | SEC | |
| Dec 22, 2023 | Dec 27, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 10,000 | $1.3M | 33.9% | Routine | SEC |
| Dec 22, 2023 | Dec 22, 2023 | NBIX | Officer | Form 144 notice | 10,000 | $1.2M | Notice | SEC | |
| Dec 12, 2023 | Dec 14, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 13,925 | $1.7M | 32.1% | Routine | SEC |
| Dec 8, 2023 | Dec 11, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 77,679 | $9.4M | 72.5% | Unusual | SEC |
| Dec 6, 2023 | Dec 8, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 8,396 | $1M | 22.1% | Routine | SEC |
| Dec 6, 2023 | Dec 6, 2023 | NBIX | Officer | Form 144 notice | 100,000 | $11.9M | Notice | SEC | |
| Aug 22, 2023 | Aug 22, 2023 | NBIX | Officer | Form 144 notice | 3,198 | $346k | Notice | SEC | |
| Aug 21, 2023 | Aug 23, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 3,198 | $343k | 9.8% | Routine | SEC |
| Apr 24, 2023 | Apr 26, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 14,400 | $1.5M | 35.1% | Unusual | SEC |
| Apr 24, 2023 | Apr 24, 2023 | NBIX | Officer | Form 144 notice | 14,400 | $1.5M | Notice | SEC | |
| Feb 8, 2023 | Feb 8, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 16,525 | $1.7M | 28.7% | Unusual | SEC |
| Jan 31, 2023 | Feb 2, 2023 | NBIX | Chief Medical Officer | Form 4 sale | 1,457 | $160k | 5.3% | Plan not stated | SEC |
| Feb 8, 2022 | Feb 9, 2022 | NBIX | Chief Medical Officer | Form 4 sale | 3,724 | $300k | 13.1% | Plan not stated | SEC |
| Jan 10, 2022 | Jan 12, 2022 | NBIX | Chief Medical Officer | Form 4 sale | 2,632 | $196k | 11.0% | Plan not stated | SEC |
| Feb 8, 2021 | Feb 9, 2021 | NBIX | Chief Medical Officer | Form 4 sale | 2,363 | $276k | 11.2% | Plan not stated | SEC |
| Jan 8, 2021 | Jan 12, 2021 | NBIX | Chief Medical Officer | Form 4 sale | 2,632 | $292k | 14.2% | Plan not stated | SEC |
| Nov 12, 2020 | Nov 16, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 2,257 | $205k | 14.3% | Plan not stated | SEC |
| Aug 5, 2020 | Aug 7, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 2,257 | $268k | 16.5% | Plan not stated | SEC |
| Jun 23, 2020 | Jun 25, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 5,000 | $650k | 34.7% | Unusual | SEC |
| Apr 24, 2020 | Apr 28, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 1,934 | $192k | 17.0% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 11, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 1,623 | $168k | 17.9% | Plan not stated | SEC |
| Jan 8, 2020 | Jan 10, 2020 | NBIX | Chief Medical Officer | Form 4 sale | 2,632 | $292k | 30.5% | Unusual | SEC |
| Jan 8, 2019 | Jan 10, 2019 | NBIX | Chief Medical Officer | Form 4 sale | 1,857 | $156k | 37.1% | Unusual | SEC |